growth hormone, liraglutide, AgRP
Showing 1 - 25 of >10,000
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
The AgRP and GH/IGF-1 Axis in Children
Not yet recruiting
- Growth Hormone Deficiency
- (no location specified)
Dec 8, 2022
A Prospective Study of Outcome After Therapy for Acromegaly
Active, not recruiting
- Acromegaly
- Surgery for acromegaly
- +3 more
-
New York, New YorkNeuroendocrine Unit; Columbia University Medical Center, 180 For
Oct 24, 2022
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Taking Daily Growth Hormone Injections to Weekly Ngenla in Low
Not yet recruiting
- Pediatric Growth Hormone Deficiency
- Sharps bin to collect used needles/injections
- (no location specified)
Nov 1, 2023
Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild Trial (Growth Hormone, Placebo)
Not yet recruiting
- Growth Hormone Treatment
- +3 more
- Growth Hormone
- Placebo
- (no location specified)
Dec 13, 2022
Growth Hormone Deficiency Trial in New York (Blood draws, Growth hormone releasing hormone (GHRH) and arginine, Carotid
Terminated
- Growth Hormone Deficiency
- Blood draws
- +4 more
-
New York, New YorkColumbia University, College of Physicians and Surgeons
Oct 24, 2022
Healthy, Type 1 Diabetes Trial in Tartu (Placebo, Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector)
Not yet recruiting
- Healthy
- Type 1 Diabetes
- Placebo
- Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector
-
Tartu, EstoniaTartu University Hospital
Apr 7, 2023
Quality of Life, Clinical Response and Safety of Daily and
Recruiting
- Growth Hormone Deficiency
- Growth Hormone Treatment
- Long-Acting Growth Hormone (LAGH)
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 29, 2022
Growth Disorders Trial in Washington (Somatropin)
Enrolling by invitation
- Growth Disorders
-
Washington, District of ColumbiaChildren's National Hospital
Aug 29, 2022
Sogroya® in Short Stature Due to Growth Hormone Deficiency Where
Recruiting
- Growth Hormone Deficiency in Children
-
Tokyo, JapanNovo Nordisk Investigational Site
Oct 25, 2023
Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)
Not yet recruiting
- Breast Neoplasms
- Disitamab Vedotin
- Toripalimab
-
Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
- +2 more
Oct 23, 2023
Information Integrated Nurse-led Monitoring Clinic
Active, not recruiting
- Short Stature
- Growth Hormone Treatment
- integrated information and nurse led telephone clinic
-
Manchester, United KingdomIndraneel Banerjee
Jan 17, 2023
Growth Hormone Deficiency Trial in Centennial (No intervention)
Recruiting
- Growth Hormone Deficiency
- No intervention
-
Centennial, ColoradoAscendis Pharma Investigational Site
Apr 18, 2023
Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)
Recruiting
- Obesity
- POSE2.0 Endoscopic Gastric Remodeling
- Liraglutide injection
-
Ras al-Khaimah, United Arab EmiratesIbrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023
Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)
Not yet recruiting
- Polycystic Ovary
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 28, 2023
Poor Ovarian Reserve Trial in Bani Suwayf (4 IU of recombinant GH (Somatotropin ))
Recruiting
- Poor Ovarian Reserve
- 4 IU of recombinant GH (Somatotropin )
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university
Oct 27, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Ocala, FloridaOcala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023
Breast Cancer Trial (Trastuzumab Deruxtecan)
Not yet recruiting
- Breast Cancer
- Trastuzumab Deruxtecan
- (no location specified)
Jul 10, 2023
Effect of Exogenous Growth Hormone on Ocular Findings
Recruiting
- Precocious Puberty
- +2 more
-
Isfahan, Iran, Islamic Republic of
- +1 more
Apr 15, 2022
Ribociclib in Combination With Hormonal Therapy in HR+/HER2-
Not yet recruiting
- Breast Cancer
- ribociclib
- (no location specified)
Oct 10, 2023
Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)
Active, not recruiting
- Breast Adenocarcinoma
- +6 more
- Anastrozole
- +6 more
-
Anniston, Alabama
- +1230 more
Jan 28, 2023
Growth Hormone Deficiency Trial in Santiago (LUM-201)
Recruiting
- Growth Hormone Deficiency
-
Santiago, ChileInstitute of Maternal and Child Research, University of Chile
Jul 12, 2022